Targeted DNA RNA Sequencing Market Size, Share & Trends Analysis Report By Product (NGS), By Workflow (Pre-sequencing), By Application, By Technology, By Type, By End Use, And Segment Forecasts, 2024

Description

Targeted DNA RNA Sequencing Market Growth & Trends:

The global targeted DNA RNA sequencing market size is expected to reach USD 34.56 billion in 2030 and is projected to grow at a CAGR of 19.4% from 2024 to 2030. Targeted Sequencing has emerged as a key technology in life science research by enabling examination of a specific region of interest while keeping the seq. cost as well as the complexity of data under manageable limits.

This approach enhances sequencing depth by allowing the evaluation of specific coding regions within genes or specific genes, which are known to harbor mutations for disease pathogenesis. Several research projects have employed this technology to avoid wastage of information and extra cost and study only relevant genes. The number of such projects continues to grow, consequently driving the market.

Innovations to address the pitfalls of targeted enrichment methods are anticipated to enhance the usage rate of this technology throughout the forecast period. Moreover, with a decrease in seq-cost and improvement in informatics, targeted methods have become more accessible for use in clinical settings than ever.

Targeted DNA RNA Sequencing Market Report Highlights:

Rapid advancements in NGS and its ancillary protocols can be attributed to the growth of this segment.
Out of all the NGS-based targeted methods, exome-seq held the largest share.
This can be attributed to the fact that though it accounts for less than 2% of the genome, it contains 85% of the known disease-relevant variants.
Entire targeted approach is broken down into presequencing, sequence determination, and data analysis.
Being the most crucial step, sequencing accounted for the largest share.
This space has revolutionized various applications of life sciences, including human biomedical research, plant & animal sciences, drug discovery, and others.
Out of all, human biomedical research is estimated to be the largest application of this space due to its high usage in studying disease pathogenesis.
The targeted DNA/RNA sequencing market is bifurcated into DNA-seq and RNA-seq, based on the sample type.
DNA-sequencing has been estimated to generate higher revenue over its counterpart segment. This can be attributed to the presence of a wide range of products and kits for DNA-seq.
As per end use, academic research is estimated to be the largest segment owing to the increase in seq-based projects at universities and other academic centers.
North America held the largest share owing to the presence of effective regulations pertaining to approval of genetic tests and bioinformatics tools.
Moreover, the U.S. is observed to have the highest number of installed sequencers, which in turn, has contributed to the large share of the North America regional market.
Asia Pacific is expected to emerge as the fastest growing regional market.
Rise in genome-based projects coupled with constant GDP growth in Asian countries is expected to drive the Asia Pacific market.

Product Code: GVR-1-68038-681-3

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Targeted DNA RNA Sequencing Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Targeted DNA RNA Sequencing Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Targeted DNA RNA Sequencing Market: Technology Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Targeted DNA RNA Sequencing Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
4.3. NGS
- 4.3.1. NGS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.2. Method Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.1. Exome Sequencing
    - 4.3.2.1.1. Exome Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.2. Enrichment Sequencing
    - 4.3.2.2.1. Enrichment Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.3. Amplicon Sequencing
    - 4.3.2.3.1. Amplicon Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.3.2.4. Others
    - 4.3.2.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.3. Application Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.3.3.1. Cancer Gene Sequencing
  - 4.3.3.2. Cancer Gene Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.3.3.3. Inherited Disease Screening
  - 4.3.3.4. Inherited Disease Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.3.3.5. Drug Development
  - 4.3.3.6. Drug Development Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.3.3.7. Forensic Genomics
  - 4.3.3.8. Forensic Genomics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.3.3.9. 16S Ribosomal RNA (rRNA)
  - 4.3.3.10. 16S Ribosomal RNA (rRNA) Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Others
- 4.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Targeted DNA RNA Sequencing Market: Workflow Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Targeted DNA RNA Sequencing Market: Workflow Movement Analysis, 2023 & 2030 (USD Million)
5.3. Pre-sequencing
- 5.3.1. Pre-sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Sequencing
- 5.4.1. Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Data Analysis
- 5.5.1. Data Analysis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Targeted DNA RNA Sequencing Market: Application Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Targeted DNA RNA Sequencing Market: Application Movement Analysis, 2023 & 2030 (USD Million)
6.3. Human Biomedical Research
- 6.3.1. Human Biomedical Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Plant & Animal Sciences
- 6.4.1. Plant & Animal Sciences Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Drug Discovery
- 6.5.1. Drug Discovery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Others
- 6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Targeted DNA RNA Sequencing Market: Type Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Targeted DNA RNA Sequencing Market: Type Movement Analysis, 2023 & 2030 (USD Million)
7.3. DNA Based Targeted Sequencing
- 7.3.1. DNA Based Targeted Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. RNA Based Targeted Sequencing
- 7.4.1. RNA Based Targeted Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Targeted DNA RNA Sequencing Market: End Use Estimates & Trend Analysis

8.1. Segment Dashboard
8.2. Targeted DNA RNA Sequencing Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
8.3. Academic Research
- 8.3.1. Academic Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Hospitals & Clinics
- 8.4.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Pharma & Biotech Entities
- 8.5.1. Pharma & Biotech Entities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Others
- 8.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Targeted DNA RNA Sequencing Market: Regional Estimates & Trend Analysis

9.1. Targeted DNA RNA Sequencing Market Share, By Region, 2023 & 2030 (USD Million)
9.2. North America
- 9.2.1. North America Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.2.2. U.S.
  - 9.2.2.1. U.S. Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.2.3. Canada
  - 9.2.3.1. Canada Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.2.4. Mexico
  - 9.2.4.1. Mexico Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3. Europe
- 9.3.1. Europe Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.2. UK
  - 9.3.2.1. UK Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.3. Germany
  - 9.3.3.1. Germany Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.4. France
  - 9.3.4.1. France Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.5. Italy
  - 9.3.5.1. Italy Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.6. Spain
  - 9.3.6.1. Spain Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.7. Denmark
  - 9.3.7.1. Denmark Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.8. Sweden
  - 9.3.8.1. Sweden Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.9. Norway
  - 9.3.9.1. Norway Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4. Asia Pacific
- 9.4.1. Asia Pacific Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.2. China
  - 9.4.2.1. China Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.3. Japan
  - 9.4.3.1. Japan Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.4. India
  - 9.4.4.1. India Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.5. South Korea
  - 9.4.5.1. South Korea Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.6. Australia
  - 9.4.6.1. Australia Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.4.7. Thailand
  - 9.4.7.1. Thailand Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5. Latin America
- 9.5.1. Latin America Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.2. Brazil
  - 9.5.2.1. Brazil Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5.3. Argentina
  - 9.5.3.1. Argentina Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6. Middle East and Africa
- 9.6.1. Middle East and Africa Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.6.2. Saudi Arabia
  - 9.6.2.1. Saudi Arabia Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.6.3. UAE
  - 9.6.3.1. UAE Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.6.4. South Africa
  - 9.6.4.1. South Africa Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.6.5. Kuwait
  - 9.6.5.1. Kuwait Targeted DNA RNA Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

10.1. Recent Developments & Impact Analysis by Key Market Participants
10.2. Company Categorization
10.3. Company Heat Map Analysis
10.4. Company Profiles
- 10.4.1. Illumina
  - 10.4.1.1. Participant's Overview
  - 10.4.1.2. Financial Performance
  - 10.4.1.3. Product Benchmarking
  - 10.4.1.4. Recent Developments/Strategic Initiatives
- 10.4.2. F. Hoffman-La Roche Ltd.
  - 10.4.2.1. Participant's Overview
  - 10.4.2.2. Financial Performance
  - 10.4.2.3. Product Benchmarking
  - 10.4.2.4. Recent Developments/Strategic Initiatives
- 10.4.3. QIAGEN
  - 10.4.3.1. Participant's Overview
  - 10.4.3.2. Financial Performance
  - 10.4.3.3. Product Benchmarking
  - 10.4.3.4. Recent Developments/Strategic Initiatives
- 10.4.4. Thermo Fisher Scientific, Inc.
  - 10.4.4.1. Participant's Overview
  - 10.4.4.2. Financial Performance
  - 10.4.4.3. Product Benchmarking
  - 10.4.4.4. Recent Developments/Strategic Initiatives
- 10.4.5. Bio-Rad Laboratories, Inc.
  - 10.4.5.1. Participant's Overview
  - 10.4.5.2. Financial Performance
  - 10.4.5.3. Product Benchmarking
  - 10.4.5.4. Recent Developments/ Strategic Initiatives
- 10.4.6. Oxford Nanopore Technologies
  - 10.4.6.1. Participant's Overview
  - 10.4.6.2. Financial Performance
  - 10.4.6.3. Product Benchmarking
  - 10.4.6.4. Recent Developments/Strategic Initiatives
- 10.4.7. PierianDx
  - 10.4.7.1. Participant's Overview
  - 10.4.7.2. Financial Performance
  - 10.4.7.3. Product Benchmarking
  - 10.4.7.4. Recent Developments/Strategic Initiatives
- 10.4.8. Genomatix GmbH
  - 10.4.8.1. Participant's Overview
  - 10.4.8.2. Financial Performance
  - 10.4.8.3. Product Benchmarking
  - 10.4.8.4. Recent Developments/Strategic Initiatives
- 10.4.9. DNASTAR, Inc.
  - 10.4.9.1. Participant's Overview
  - 10.4.9.2. Financial Performance
  - 10.4.9.3. Product Benchmarking
  - 10.4.9.4. Recent Developments/Strategic Initiatives
- 10.4.10. Perkin Elmer, Inc.
  - 10.4.10.1. Participant's Overview
  - 10.4.10.2. Financial Performance
  - 10.4.10.3. Product Benchmarking
  - 10.4.10.4. Recent Developments/Strategic Initiatives

Targeted DNA RNA Sequencing Market Size, Share & Trends Analysis Report By Product (NGS), By Workflow (Pre-sequencing), By Application, By Technology, By Type, By End Use, And Segment Forecasts, 2024 - 2030